<DOC>
	<DOCNO>NCT00002922</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness paclitaxel treat patient recurrent metastatic head neck cancer .</brief_summary>
	<brief_title>Paclitaxel Treating Patients With Advanced Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate response rate toxic effect paclitaxel 96 hour continuous infusion chemotherapy naive chemotherapy expose patient recurrent metastatic squamous cell carcinoma head neck . OUTLINE : Patients receive paclitaxel 96 hour continuous IV infusion . Courses repeat every 3 week maximum 12 course . Patients disease progression 2 course unacceptable toxicity time remove study . PROJECTED ACCRUAL : Approximately 109 patient accrue study 4 year .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven squamous cell carcinoma head neck ( include nasopharynx ) consider incurable surgery radiation therapy Bidimensionally measurable disease Patients whose site measurable disease within previous radiation port must document progressive disease biopsyproven recurrence completion radiotherapy No uncontrolled CNS metastases PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 0 1 Hematopoietic : Absolute neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.5 mg/dL Renal : Creatinine great 1.5 mg/dL OR Creatinine clearance least 60 mL/min Calcium normal No history hypercalcemia Cardiovascular : No history ventricular arrhythmia symptomatic bradyarrhythmia Other : No significant detectable infection Not pregnant nursing No active malignancy Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Prior interleukin2 , interferon , monoclonal antibody allow Recovered prior therapy Chemotherapy : Prior paclitaxel infusion great 24 hour recurrent metastatic disease require Endocrine therapy : Not specify Radiotherapy : Recovered prior radiotherapy Surgery : Recovered prior major surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
</DOC>